NCT03856242View on ClinicalTrials.gov

Benign Prostatic Hyperplasia and Ischemic Heart DIsease

PHASE4CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

September 1, 2015

Primary Completion Date

September 1, 2017

Study Completion Date

September 1, 2017

Conditions
Ischaemic Heart Disease (IHD)Benign Prostatic Hyperplasia (BPH)Lower Urinary Tract Symptoms (LUTS)
Interventions
DRUG

Tamsulosin Oral Capsule

Tamsulosin Oral Capsule - alpha-1-adrenoblocker for treatment LUTS/BPH 0.4 mg

PROCEDURE

TURP

Routine transurethral prostatic resection

All Listed Sponsors
lead

I.M. Sechenov First Moscow State Medical University

OTHER

NCT03856242 - Benign Prostatic Hyperplasia and Ischemic Heart DIsease | Biotech Hunter | Biotech Hunter